Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.7 USD | -1.67% | +7.06% | +80.08% |
07/05 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
01/05 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
EBIT
- Stock Market
- Equities
- SMMT Stock
- Revisions Summit Therapeutics Inc.